What drugs does ASCENDIS PHARMA BONE make?

ASCENDIS PHARMA BONE has 1 FDA-approved drugs including YORVIPATH.

What therapeutic areas does ASCENDIS PHARMA BONE focus on?

ASCENDIS PHARMA BONE focuses primarily on Metabolic.

← Back

Data updated: Mar 29, 2026

ASCENDIS PHARMA BONE

Metabolic

Pharma

ASCENDIS PHARMA BONE is a pharmaceutical company focused on Metabolic. Key products include YORVIPATH.

2024

Since

Drugs

Trials

Approved (2yr)

Key Drugs

YORVIPATH

palopegteriparatide

PTH1R 1 indications · 2024

Top Drug Revenues ProEarly access

Revenue Over Time ProEarly access

Recent Activity

YORVIPATH 2025-10-16

Manufacturing (CMC)

YORVIPATH 2024-08-09

Type 1 - New Molecular Entity

SEC Filings ProEarly access

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Metabolic 100%

1 drugs Phase 3: 2

Pipeline Forecast

Upcoming Trial Milestones ProEarly access

Patent Cliff ProEarly access

Competitors by Therapeutic Area

Merck big-pharma

Metabolic

Johnson & Johnson big-pharma

Metabolic

OTSUKA ICU MEDCL specialty

ASCENDIS PHARMA BONE

Key Drugs

Top Drug Revenues ProEarly access

Revenue Over Time ProEarly access

Recent Activity

Therapeutic Areas

Pipeline Forecast

Upcoming Trial Milestones ProEarly access

Patent Cliff ProEarly access

Competitors by Therapeutic Area

All Drugs (1)

Active (1)

Discontinued (0)

Company Info

ASCENDIS PHARMA BONE

Set Alert

Key Drugs

Top Drug Revenues ProEarly access

Revenue Over Time ProEarly access

Recent Activity

Therapeutic Areas

Pipeline Forecast

Upcoming Trial Milestones ProEarly access

Patent Cliff ProEarly access

Competitors by Therapeutic Area

All Drugs (1)

Active (1)

Discontinued (0)

Company Info